News articles about Colgate-Palmolive (NYSE:CL) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Colgate-Palmolive earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.1149785475057 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the news articles that may have impacted Accern Sentiment’s scoring:
- Insider Selling: Colgate-Palmolive Company (CL) Insider Sells 9,000 Shares of Stock (americanbankingnews.com)
- Colgate-Palmolive (CL) Shares Cross Below 200 DMA – Nasdaq (nasdaq.com)
- Who Might Acquire Colgate-Palmolive? (seekingalpha.com)
- What’s the Story?: EQT Corporation, (NYSE: EQT), Colgate-Palmolive Company, (NYSE: CL), Comcast Corporation … – Stocks In The News (press release) (tradingnewsnow.com)
- Bernstein talks Amazon aftershocks – Seeking Alpha (seekingalpha.com)
Several research analysts have recently commented on the company. SunTrust Banks, Inc. raised Colgate-Palmolive from a “hold” rating to a “buy” rating and boosted their price target for the stock from $65.00 to $85.00 in a research report on Wednesday, October 11th. Citigroup Inc. reduced their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research report on Thursday, November 2nd. Stifel Nicolaus set a $73.00 price target on Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Finally, Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. One investment analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $76.67.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the business earned $0.73 earnings per share. The company’s revenue was up 2.8% compared to the same quarter last year. equities research analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were paid a $0.40 dividend. The ex-dividend date was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.22%. Colgate-Palmolive’s payout ratio is 61.78%.
In related news, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the transaction, the director now owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of the company’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total value of $660,690.00. The disclosure for this sale can be found here. Insiders sold 173,673 shares of company stock worth $12,629,293 in the last 90 days. Company insiders own 1.02% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive (CL) Earning Somewhat Positive News Coverage, Study Shows” was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/11/20/colgate-palmolive-cl-earning-somewhat-positive-news-coverage-study-shows.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
What are top analysts saying about Colgate-Palmolive Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive Company and related companies.